About Van Leer Technology Ventures
Van Leer Technology Ventures is a venture capital firm founded in 1992. It is primarily based out of Jerusalem, Israel. As of Jun 2011, Van Leer Technology Ventures has invested in 30 companies. It primarily invests in Seed round in Israel based startups. Its investments are spread across a wide range of sectors from Life Sciences to Enterprise Applications and HealthTech. Most recently it participated in the $***** Series A round of Opticul Diagnostics Overall, Van Leer Technology Ventures portfolio has seen 2 acquisitions, namely PeriGen and DBSophic. A lot of funds co-invest with Van Leer Technology Ventures, with names like Shaked Ventures sharing a substantial percentage of its portfolio.Key Metrics
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed & Series A
Van Leer Technology Ventures' List of Top Investments
Van Leer Technology Ventures has a portfolio of 30 companies. Their most notable investments include EyeYon and Omnix Medical.Their portfolio spans across Israel and United States. They have invested in Life Sciences, Enterprise Applications, HealthTech and 9 other sectors, across stages such as Seed, Series A stages. Here is the list of top investments by Van Leer Technology Ventures:1. EyeYon
Developer of ophthalmic devices for the treatment of corneal edema. The Hyper-CL™ therapeutic contact lens for the treatment of corneal pathologies. Another product EndoArt is a polymer film implant that is attached to the posterior corneal surface to treat corneal edema secondary to endothelial dysfunction.
Key facts about EyeYon
- Founded Year: 2011
- Location: Ness Ziona (Israel)
- Stage: Series C
- Total Funding till date: $36M
- Employee Count: 19 as on Jul 01, 2024
- Investors: Pontifax, Triventures and 10 Others
- Latest Funding Round: Series C, Mar 15, 2021, $*****
- Highlight: Editors' Pick
Developer of antimicrobial peptides for the treatment of drug-resistant bacterial infections. The lead candidate OMN6 targets gram-negative bacteria. Other candidates include OMN-XF for multi-drug resistance fungi and OMN-XGP for gram-positive bacteria. The technology is based on natural antimicrobial peptides which are genetically engineered for stability and for proteolytic degradation pruning.
Key facts about Omnix Medical
3. PeriGen
Advanced perinatal software solutions improving patient safety and clinical efficiency. The company offers innovative software solutions leveraging advanced statistical analysis to enhance clinical efficiency and standardize care during childbirth. The PeriWatch platform provides consistent analysis and efficient display of complex data in real-time, promoting better human recognition and communication about impending problems during labor. Clinicians can spend more time on direct patient care and less time on manual calculations and data manipulation. Designed by clinicians, for clinicians, the software complements current workflows and promotes patient safety. The company seamlessly integrates with current EMR and EFM systems. The solutions utilize Artifical Intelligence and offer maternal-fetal surveillance and early warning system. It is a SaaS based platform.
Key facts about PeriGen
- Founded Year: 1995
- Location: Cranbury (United States)
- Stage: Acquired
- Total Funding till date: $11M
- Employee Count: 49 as on Dec 31, 2022
- Investors: Salmon River Capital, Trident Capital and 4 Others
- Latest Funding Round: Series B, Sep 27, 2016, $*****
- Highlight: Acquired
4. OCON Medical
Developer of nitinol based contraceptive devices for womens health, It develops intrauterine devices (IUD) made from Nitinol for contraception & IUB copper pearls consist of a special shape memory alloy. Once the flexible IUB frame is released from the insertion tube in the uterus. It offers IUB BALLERINE hormone-free smart IUD, IUB SEAD a endometrial ablation device, and IUB PRIMA for therapeutic-delivery to target therapy areas such as endometriosis and myomas.
Key facts about OCON Medical
Raziel Therapeutics has developed a proprietary drug for the treatment of local fat reduction. It has developed a new chemical entity (NCE) called RZL-12. RZL-12 is injected into subcutaneous fat to convert white adipose tissue (WAT) into brown adipose tissue-like to treat obesity and overweight disease.
Key facts about Raziel Therapeutics
Van Leer Technology Ventures' Investments by Stage
Van Leer Technology Ventures has made 3 investments in Seed stage with an average round size of $883K and 1 investment in Series A stage with an average round size of $1.7M.Stage of entry | No. of Investments |
|---|---|
Seed | 3 |
Series A | 1 |
Note: We have considered here, only first round of investments
Van Leer Technology Ventures' Investments by Sector
Van Leer Technology Ventures has a diverse portfolio, with companies operating in the Life Sciences, Sustainability Tech, Consumer, Enterprise Applications and Enterprise Infrastructure. Notably, it has invested in 22 Enterprise (B2B) companies, 21 Tech companies, 13 Software companies and at least 7 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Life Sciences | 2 |
Sustainability Tech | 2 |
Consumer | 1 |
Enterprise Applications | 1 |
Enterprise Infrastructure | 1 |
Others | 4 |
Note: We have considered here, only first round of investments
Van Leer Technology Ventures' Investments by Geography
Van Leer Technology Ventures has made most investments in Israel (4).Van Leer Technology Ventures' recent investments
Van Leer Technology Ventures has not made any investment in 2026 so far.Here are the most recent investments by Van Leer Technology Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jun 22, 2011 | Israel | Series A | 1117 | [+1] | |
2010 | Israel | Seed | 5710 | ||
Nov 14, 2007 | Israel | Seed | 9437 | ||
Nov 07, 2006 | Israel | Seed | 1103 | - |
Acquired companies in Van Leer Technology Ventures' Portfolio
2 companies from Van Leer Technology Ventures' portfolio have been acquired. The most recent acquisition was PeriGen in Apr 2021 by Halma for $*****.Here are Van Leer Technology Ventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Apr 27, 2021 | - | - | 7217 | |
Apr 01, 2013 | Nov 14, 2007 | Seed | 6143 |
Co-investors of Van Leer Technology Ventures
Over the past 20 years, 11 investors have co-invested in Van Leer Technology Ventures's portfolio companies. This includes funds and angels.
- Top Co-investors of Van Leer Technology Ventures: 4 investors entered a company along with Van Leer Technology Ventures. These include investors like Shaked Ventures (1 company).
- Invested after Van Leer Technology Ventures: A total of 7 investors have invested in Van Leer Technology Ventures's portfolio after their investments. Top Investors include EIC Fund (1 company), Europa (1 company) and Flex (1 company).
Recent News related to Van Leer Technology Ventures
•
•
•
SimilarGroup raises $3.5M, goes Live with SimilarWeb ProGeektime•Sep 24, 2013•SimilarWeb, Docor, Van Leer Technology Ventures
•
Online metrics co SimilarWeb raising $3.5m - Globes
Globes•Sep 24, 2013•SimilarWeb, Docor, Van Leer Technology Ventures
